• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-613 通过调控 PDK1 抑制喉鳞状细胞癌的进展。

MiR-613 suppressed the laryngeal squamous cell carcinoma progression through regulating PDK1.

机构信息

Department of Otolaryngology, Liaocheng People's Hospital and EENT Hospital, Liaocheng, Shandong, China.

出版信息

J Cell Biochem. 2018 Jul;119(7):5118-5125. doi: 10.1002/jcb.26468. Epub 2018 Apr 6.

DOI:10.1002/jcb.26468
PMID:29091303
Abstract

MicroRNAs (miRNAs) are aberrantly expressed in several tumors and play important role in tumorigenesis. However, little is known about the role of miR-613 in laryngeal squamous cell carcinoma (LSCC). We determined the expression of miR-613 in a panel of 30 LSCC specimens. Compared with the adjacent normal samples, 20 cases of LSCC tissues exhibited decreased expression of miR-613. The average expression of miR-613 in LSCC tissues was lower than in normal samples. Moreover, we demonstrated that exogenous expression of miR-613 suppressed LSCC cell proliferation, invasion, and blocked G1/S phase transition. We identified that 3-phosphoinositide-dependent protein kinase-1 (PDK1) was a direct target gene of miR-613 in LSCC cell. Overexpression of miR-613 suppressed PDK1 expression in LSCC cell. Furthermore, we demonstrated that PDK1 was upregulated in LSCC tissues. MiR-613 expression was inversely correlated with the expression of PDK1 in LSCC tissues. Moreover, we showed that PDK1 was involved in the miR-613-mediated cancer suppression of LSCC cell. These results suggested that miR-613 played as a tumor suppressor gene in LSCC partly by inhibiting PDK1 expression.

摘要

微小 RNA(miRNAs)在多种肿瘤中表达异常,在肿瘤发生中发挥重要作用。然而,miR-613 在喉鳞状细胞癌(LSCC)中的作用知之甚少。我们在 30 个 LSCC 标本中确定了 miR-613 的表达。与相邻的正常样本相比,20 例 LSCC 组织表现出 miR-613 的表达降低。LSCC 组织中 miR-613 的平均表达低于正常样本。此外,我们证明外源性表达 miR-613 可抑制 LSCC 细胞增殖、侵袭,并阻断 G1/S 期转变。我们确定 3-磷酸肌醇依赖性蛋白激酶-1(PDK1)是 LSCC 细胞中 miR-613 的直接靶基因。miR-613 的过表达可抑制 LSCC 细胞中 PDK1 的表达。此外,我们证明 PDK1 在 LSCC 组织中上调。miR-613 的表达与 LSCC 组织中 PDK1 的表达呈负相关。此外,我们表明 PDK1 参与了 miR-613 介导的 LSCC 细胞的肿瘤抑制作用。这些结果表明,miR-613 通过抑制 PDK1 的表达,在 LSCC 中部分发挥肿瘤抑制基因的作用。

相似文献

1
MiR-613 suppressed the laryngeal squamous cell carcinoma progression through regulating PDK1.miR-613 通过调控 PDK1 抑制喉鳞状细胞癌的进展。
J Cell Biochem. 2018 Jul;119(7):5118-5125. doi: 10.1002/jcb.26468. Epub 2018 Apr 6.
2
MicroRNA-4497 functions as a tumor suppressor in laryngeal squamous cell carcinoma via negatively modulation the GBX2.微小RNA-4497通过负向调节GBX2在喉鳞状细胞癌中发挥肿瘤抑制作用。
Auris Nasus Larynx. 2019 Feb;46(1):106-113. doi: 10.1016/j.anl.2018.05.005. Epub 2018 May 26.
3
miR-206 inhibits human laryngeal squamous cell carcinoma cell growth by regulation of cyclinD2.微小RNA-206通过调控细胞周期蛋白D2抑制人喉鳞状细胞癌细胞的生长。
Eur Rev Med Pharmacol Sci. 2015;19(14):2697-702.
4
miR-205 promotes proliferation and invasion of laryngeal squamous cell carcinoma by suppressing CDK2AP1 expression.微小RNA-205通过抑制细胞周期蛋白依赖性激酶2相关蛋白1的表达促进喉鳞状细胞癌的增殖和侵袭。
Biol Res. 2015 Oct 29;48:60. doi: 10.1186/s40659-015-0052-5.
5
MicroRNA-101 is a potential prognostic indicator of laryngeal squamous cell carcinoma and modulates CDK8.微小RNA-101是喉鳞状细胞癌的一种潜在预后指标,并调节细胞周期蛋白依赖性激酶8。
J Transl Med. 2015 Aug 19;13:271. doi: 10.1186/s12967-015-0626-6.
6
CircRASSF2 promotes laryngeal squamous cell carcinoma progression by regulating the miR-302b-3p/IGF-1R axis.环状 RNA Ras 相关区域家族 2 通过调控 miR-302b-3p/胰岛素样生长因子-1 受体轴促进喉鳞状细胞癌的进展。
Clin Sci (Lond). 2019 May 9;133(9):1053-1066. doi: 10.1042/CS20190110. Print 2019 May 15.
7
MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.微小RNA 744-3p通过同时抑制喉鳞状细胞癌中的PDCD4和PTEN促进基质金属蛋白酶-9介导的转移。
Oncotarget. 2016 Sep 6;7(36):58218-58233. doi: 10.18632/oncotarget.11280.
8
Long non-coding RNA LOC554202 promotes laryngeal squamous cell carcinoma progression through regulating miR-31.长链非编码RNA LOC554202通过调控miR-31促进喉鳞状细胞癌进展。
J Cell Biochem. 2018 Aug;119(8):6953-6960. doi: 10.1002/jcb.26902. Epub 2018 May 8.
9
Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression.下调 miR-206 通过调节 VEGF 表达促进喉癌的增殖和侵袭。
Anticancer Res. 2011 Nov;31(11):3859-63.
10
MiR-125b-5p suppressed the glycolysis of laryngeal squamous cell carcinoma by down-regulating hexokinase-2.miR-125b-5p 通过下调己糖激酶-2 抑制喉鳞状细胞癌的糖酵解。
Biomed Pharmacother. 2018 Jul;103:1194-1201. doi: 10.1016/j.biopha.2018.04.098. Epub 2018 May 7.

引用本文的文献

1
[Research Progress of Engineered Exosomes in the Treatment of Lung Cancer].[工程化外泌体治疗肺癌的研究进展]
Zhongguo Fei Ai Za Zhi. 2024 Jul 20;27(7):535-540. doi: 10.3779/j.issn.1009-3419.2024.101.17.
2
Diagnostic and Prognostic Value of microRNAs in Patients with Laryngeal Cancer: A Systematic Review.微小RNA在喉癌患者中的诊断和预后价值:一项系统评价
Noncoding RNA. 2023 Jan 19;9(1):9. doi: 10.3390/ncrna9010009.
3
Engineered Exosomes Loaded with miR-563 Inhibit Lung Cancer Growth.装载miR-563的工程化外泌体抑制肺癌生长。
J Oncol. 2022 Jun 6;2022:6141857. doi: 10.1155/2022/6141857. eCollection 2022.
4
Molecular mechanism, regulation, and therapeutic targeting of the STAT3 signaling pathway in esophageal cancer (Review).STAT3 信号通路在食管癌中的分子机制、调控及治疗靶点(综述)。
Int J Oncol. 2022 Sep;61(3). doi: 10.3892/ijo.2022.5395. Epub 2022 Jul 20.
5
Ribophorin II promotes the epithelial-mesenchymal transition and aerobic glycolysis of laryngeal squamous cell carcinoma via regulating reactive oxygen species-mediated Phosphatidylinositol-3-Kinase/Protein Kinase B activation.核糖蛋白 II 通过调节活性氧介导的磷脂酰肌醇-3-激酶/蛋白激酶 B 激活促进喉鳞状细胞癌的上皮-间充质转化和有氧糖酵解。
Bioengineered. 2022 Mar;13(3):5141-5151. doi: 10.1080/21655979.2022.2036914.
6
CircPTK2 (hsa_circ_0003221) Contributes to Laryngeal Squamous Cell Carcinoma by the miR-1278/YAP1 Axis.环状PTK2(hsa_circ_0003221)通过miR-1278/YAP1轴促进喉鳞状细胞癌的发生发展。
J Oncol. 2021 Oct 13;2021:2408384. doi: 10.1155/2021/2408384. eCollection 2021.
7
MiR-613 inhibits the proliferation, migration, and invasion of papillary thyroid carcinoma cells by directly targeting TAGLN2.微小RNA-613通过直接靶向Transgelin 2抑制甲状腺乳头状癌细胞的增殖、迁移和侵袭。
Cancer Cell Int. 2021 Sep 16;21(1):494. doi: 10.1186/s12935-021-02083-8.
8
Circular RNA ABCB10 contributes to laryngeal squamous cell carcinoma (LSCC) progression by modulating the miR-588/CXCR4 axis.环状 RNA ABCB10 通过调节 miR-588/CXCR4 轴促进喉鳞状细胞癌(LSCC)的进展。
Aging (Albany NY). 2021 May 18;13(10):14078-14087. doi: 10.18632/aging.203025.
9
LncRNA UCA1 elevates the resistance of human leukemia cells to daunorubicin by the PI3K/AKT pathway via sponging miR-613.长链非编码 RNA UCA1 通过海绵吸附 miR-613 经由 PI3K/AKT 通路提高人白血病细胞对柔红霉素的耐药性。
Biosci Rep. 2021 Jun 25;41(6). doi: 10.1042/BSR20201389.
10
LINC01303 promotes the proliferation and migration of laryngeal carcinoma by regulating miR-200c/TIMP2 axis.LINC01303通过调控miR-200c/TIMP2轴促进喉癌的增殖和迁移。
Am J Transl Res. 2021 Mar 15;13(3):1643-1656. eCollection 2021.